| Inhaled formulations and pulmonary drug delivery systems for respiratory infections QT Zhou, SSY Leung, P Tang, T Parumasivam, ZH Loh, HK Chan Advanced drug delivery reviews 85, 83-99, 2015 | 254 | 2015 |
| Antimicrobial resistance: Prevalence, Economic Burden, Mechanisms of Resistance and Strategies to Overcome T Pulingam, T Parumasivam, AM Gazzali, AM Sulaiman, JY Chee, ... European Journal of Pharmaceutical Sciences, 106103, 2022 | 231 | 2022 |
| L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders L Li, S Sun, T Parumasivam, JA Denman, T Gengenbach, P Tang, S Mao, ... European Journal of Pharmaceutics and Biopharmaceutics 102, 132-141, 2016 | 167 | 2016 |
| Production of inhalation phage powders using spray freeze drying and spray drying techniques for treatment of respiratory infections SSY Leung, T Parumasivam, FG Gao, NB Carrigy, R Vehring, WH Finlay, ... Pharmaceutical research 33, 1486-1496, 2016 | 129 | 2016 |
| Effects of storage conditions on the stability of spray dried, inhalable bacteriophage powders SSY Leung, T Parumasivam, FG Gao, EA Carter, NB Carrigy, R Vehring, ... International journal of pharmaceutics 521 (1-2), 141-149, 2017 | 97 | 2017 |
| Dry powder inhalable formulations for anti-tubercular therapy T Parumasivam, RYK Chang, S Abdelghany, TT Ye, WJ Britton, HK Chan Advanced drug delivery reviews 102, 83-101, 2016 | 87 | 2016 |
| Effect of storage temperature on the stability of spray dried bacteriophage powders SSY Leung, T Parumasivam, A Nguyen, T Gengenbach, EA Carter, ... European Journal of Pharmaceutics and Biopharmaceutics 127, 213-222, 2018 | 70 | 2018 |
| New thiazolyl-coumarin hybrids: Design, synthesis, characterization, X-ray crystal structure, antibacterial and antiviral evaluation H Osman, SK Yusufzai, MS Khan, BM Abd Razik, O Sulaiman, ... Journal of Molecular Structure 1166, 147-154, 2018 | 68 | 2018 |
| Alginate modified-PLGA nanoparticles entrapping amikacin and moxifloxacin as a novel host-directed therapy for multidrug-resistant tuberculosis S Abdelghany, T Parumasivam, A Pang, B Roediger, P Tang, K Jahn, ... Journal of Drug Delivery Science and Technology 52, 642-651, 2019 | 66 | 2019 |
| Synthesis and evaluation of isonicotinoyl hydrazone derivatives as antimycobacterial and anticancer agents HS Naveen Kumar, T Parumasivam, F Jumaat, P Ibrahim, MZ Asmawi, ... Medicinal Chemistry Research 23, 269-279, 2014 | 62 | 2014 |
| Rifapentine-loaded PLGA microparticles for tuberculosis inhaled therapy: Preparation and in vitro aerosol characterization T Parumasivam, SSY Leung, DH Quan, JA Triccas, WJ Britton, HK Chan European Journal of Pharmaceutical Sciences 88, 1-11, 2016 | 55 | 2016 |
| Phytochemical and pharmacological properties of Curcuma aromatica Salisb (wild turmeric) NM Umar, T Parumasivam, N Aminu, SM Toh Journal of Applied Pharmaceutical Science 10 (10), 180-194, 2020 | 52 | 2020 |
| Design, characterization, in vitro antibacterial, antitubercular evaluation and structure–activity relationships of new hydrazinyl thiazolyl coumarin derivatives S KhanYusufzai, H Osman, MS Khan, S Mohamad, O Sulaiman, ... Medicinal Chemistry Research 26, 1139-1148, 2017 | 52 | 2017 |
| Advances in nanocarriers for effective delivery of docetaxel in the treatment of lung cancer: an overview SA A. Razak, A Mohd Gazzali, FA Fisol, I M. Abdulbaqi, T Parumasivam, ... Cancers 13 (3), 400, 2021 | 40 | 2021 |
| PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection AS Ashhurst, T Parumasivam, JGY Chan, LCW Lin, M Flórido, NP West, ... PloS one 13 (3), e0194620, 2018 | 35 | 2018 |
| 4-Thiazolidinone coumarin derivatives as two-component NS2B/NS3 DENV flavivirus serine protease inhibitors: synthesis, molecular docking, biological evaluation and structure … SK Yusufzai, H Osman, MS Khan, BM Abd Razik, MO Ezzat, S Mohamad, ... Chemistry Central Journal 12, 1-16, 2018 | 32 | 2018 |
| Advances in polyhydroxyalkanoate nanocarriers for effective drug delivery: An overview and challenges P Prakash, WH Lee, CY Loo, HSJ Wong, T Parumasivam Nanomaterials 12 (1), 175, 2022 | 31 | 2022 |
| Pulmonary delivery of anticancer drugs via lipid-based nanocarriers for the treatment of lung cancer: An update IM Abdulbaqi, RA Assi, A Yaghmur, Y Darwis, N Mohtar, T Parumasivam, ... Pharmaceuticals 14 (8), 725, 2021 | 31 | 2021 |
| Antituberculosis activity, phytochemical identification of Costus speciosus (J. Koenig) Sm., Cymbopogon citratus (DC. Ex Nees) Stapf., and Tabernaemontana coronaria (L … S Mohamad, NN Ismail, T Parumasivam, P Ibrahim, H Osman, ... BMC complementary and alternative medicine 18, 1-14, 2018 | 31 | 2018 |
| In vitro evaluation of inhalable verapamil-rifapentine particles for tuberculosis therapy T Parumasivam, JGY Chan, A Pang, DH Quan, JA Triccas, WJ Britton, ... Molecular Pharmaceutics 13 (3), 979-989, 2016 | 26 | 2016 |
